Xiaoqing Sun

7PUBLICATIONS
29CO-AUTHORS
Medical devicesPredictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 25, 2026
Empagliflozin Ameliorates Experimental Pulmonary Vascular Remodeling, but May Not Benefit Patients With Pulmonary Arterial Hypertension.

|May 29, 2024
Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.

Xiao-Qing Sun, Timothy Klouda, Suzanne Barnasconi

|Jan 09, 2021
Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention.

Takayuki Jujo Sanada, Xiao-Qing Sun, Chris Happé

|Dec 02, 2020
Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.

Xiao-Qing Sun, Eva L Peters, Ingrid Schalij

|Jun 14, 2020
MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension.

Maria Catalina Gomez-Puerto, Xiao-Qing Sun, Ingrid Schalij

|Jun 12, 2020
The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.

Chris Happé, Kondababu Kurakula, Xiao-Qing Sun

Pageof 2

Frequent Collaborators

6 joint publications

Harm-Jan Bogaard

4 joint publications

Marie-José Goumans

2 joint publications

Denielli da Silva Goncalves Bos

2 joint publications

Christophe Guignabert